The latest closing stock price for Esperion Therapeutics as of November 22, 2024 is 2.52.
An investor who bought $1,000 worth of Esperion Therapeutics stock at the IPO in 2013 would have $-826 today, roughly -1 times their original investment - a -14.71% compound annual growth rate over 11 years.
The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.
The Esperion Therapeutics 52-week high stock price is 3.40, which is 34.9% above the current share price.
The Esperion Therapeutics 52-week low stock price is 1.16, which is 54% below the current share price.
The average Esperion Therapeutics stock price for the last 52 weeks is 2.21.
An investor who bought $1,000 worth of Esperion Therapeutics stock at the IPO in 2013 would have $-826 today, roughly -1 times their original investment - a -14.71% compound annual growth rate over 11 years.
The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.
The Esperion Therapeutics 52-week high stock price is 3.40, which is 34.9% above the current share price.
The Esperion Therapeutics 52-week low stock price is 1.16, which is 54% below the current share price.
The average Esperion Therapeutics stock price for the last 52 weeks is 2.21.